#ACR21 Ab#1029 - Great poster by Dr. Guttmann, IRAD in Summit NJ: ▶️2019 EULAR/ACR SLE criteria vs to 1997 ACR & SLICC ⭐️64% SLE pts: all 3 criteria. 10% only SLICC, 3% '97 ACR, 2% EULAR/ACR ⭐️Simliar gender, racial disparities to prior criteria @Rheumnow https://t.co/QzG78HJgw5 https://t.co/eyuYhj4Acf

• https://bit.ly/3H5DIqc

#ACR21 Abst#1029 @Rheumnow https://t.co/QzG78HJgw5 What is your preferred SLE classification criteria?

• https://bit.ly/3H5DIqc

#ACR21 Abs:#1429: ALPN-303: Dual BAFF/APRIL antagonist for SLE: ⭐️Encouraging immunomodulatory activity and efficacy in animal models. ⬇️ Plasma cells and Ig secretions in vitro & vivo ⭐️Well-tolerated in animals w/o adverse events 🔥Phase 1 study in healthy volunteers! @Rheumnow

#ACR21 #Abstr1420 A study checking #COVID vaccine response in 90 #lupus pts and 20 HC: ⬇️Titres of Abs in SLE vs controls 💠Factors of poor response: On any DMARDs exc HCQ only (OR 15) and normal dsDNA 📢Important to pause DMARDs in stable SLE @RheumNow https://t.co/USovFkiCRb https://t.co/bn5CC0xRS9

• Evaluation of SARS-CoV-2 Vaccine Response in a Multi-Racial/Ethnic Cohort of Pa…

📢#ACR21 #Abstr1421 Is #COVID19 vaccine safe and effective in #lupus? YES!! VOCOLUP study (N=1189 pts) showed: 💠~45% had a side-effect; of which 80% mild/moderate 💠Only 3% flared post💉(MSK + Fatigue); 10 required hospitalisation @RheumNow #ACRBest https://t.co/WF4aAfiX70 https://t.co/jc0HQoJymo

• Efficacy and Tolerance of Vaccination Against COVID-19 in Patients with Systemi…

Young patients with #SLE #lupus have a #multimorbidity burden similar to individuals 30years older than them. A high #comorbidity burden is present in SLE pts of all ages compared to non-SLE. How can we address this? Abs#1049 #ACR21 #ACRBest @RheumNow https://t.co/U6t8YBFUZz https://t.co/v7Fwof1gZc

• Multimorbidity Differences Between Systemic Lupus Erythematosus Patients and Co…

Watch: Lupus Updates: Dr. Michelle Petri Dr. Michelle Petri offers perspective and insight into lupus related data presented Saturday at the #ACR21 annual meeting. https://t.co/L7T2mNJVH0 https://t.co/MCQ7nJjCIY

• https://bit.ly/3GV3VIh

Stopping/reducing hydroxychloroquine (HCQ) in SLE associated with increased flares, especially for those in low disease activity or in remission. Super helpful data to share with pts wanting to reduce/dc HCQ. #ACR21 Abst#0959 Plenary Session II @RheumNow https://t.co/i7jPDN2sgZ

Dr FCardwell et al on Health Info use in SLE pts b4 and during COVID19 using an online survey 🦋#lupus specialists & fam physicians - ⬆preferred & trusted health info sources but access to them ⬇frequent during covid19 A call to action?📢 @RheumNow #ACR21 abs0880 @rheumarhyme https://t.co/1NBEAlFvHx